<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38689605</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-7762</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>The Lancet regional health. Europe</Title><ISOAbbreviation>Lancet Reg Health Eur</ISOAbbreviation></Journal><ArticleTitle>Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT).</ArticleTitle><Pagination><StartPage>100908</StartPage><MedlinePgn>100908</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100908</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lanepe.2024.100908</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Long COVID is a major problem affecting patient health, the health service, and the workforce. To optimise the design of future interventions against COVID-19, and to better plan and allocate health resources, it is critical to quantify the health and economic burden of this novel condition. We aimed to evaluate and estimate the differences in health impacts of long COVID across sociodemographic categories and quantify this in Quality-Adjusted Life-Years (QALYs), widely used measures across health systems.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">With the approval of NHS England, we utilised OpenPROMPT, a UK cohort study measuring the impact of long COVID on health-related quality-of-life (HRQoL). OpenPROMPT invited responses to Patient Reported Outcome Measures (PROMs) using a smartphone application and recruited between November 2022 and October 2023. We used the validated EuroQol EQ-5D questionnaire with the UK Value Set to develop disutility scores (1-utility) for respondents with and without Long COVID using linear mixed models, and we calculated subsequent Quality-Adjusted Life-Months (QALMs) for long COVID.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">The total OpenPROMPT cohort consisted of 7575 individuals who consented to data collection, with which we used data from 6070 participants who completed a baseline research questionnaire where 24.6% self-reported long COVID. In multivariable regressions, long COVID had a consistent impact on HRQoL, showing a higher likelihood or odds of reporting loss in quality-of-life (Odds Ratio (OR): 4.7, 95% CI: 3.72-5.93) compared with people who did not report long COVID. Reporting a disability was the largest predictor of losses of HRQoL (OR: 17.7, 95% CI: 10.37-30.33) across survey responses. Self-reported long COVID was associated with an 0.37 QALM loss.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">We found substantial impacts on quality-of-life due to long COVID, representing a major burden on patients and the health service. We highlight the need for continued support and research for long COVID, as HRQoL scores compared unfavourably to patients with conditions such as multiple sclerosis, heart failure, and renal disease.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">This research was supported by the National Institute for Health and Care Research (NIHR) (OpenPROMPT: COV-LT2-0073).</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carlile</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briggs</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henderson</LastName><ForeName>Alasdair D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler-Cole</LastName><ForeName>Ben F C</ForeName><Initials>BFC</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tazare</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomlinson</LastName><ForeName>Laurie A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marks</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital for Tropical Diseases, University College London Hospital, London, WC1E 6JD, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infection and Immunity, University College London, London, WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jit</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Liang-Yu</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bates</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>TPP, TPP House, 129 Low Lane, Horsforth, Leeds, LS18 5PX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parry</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>TPP, TPP House, 129 Low Lane, Horsforth, Leeds, LS18 5PX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bacon</LastName><ForeName>Sebastian C J</ForeName><Initials>SCJ</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dillingham</LastName><ForeName>Iain</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dennison</LastName><ForeName>William A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Patient and Public Involvement Steering Committee, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costello</LastName><ForeName>Ruth E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Alex J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hulme</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldacre</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehrkar</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacKenna</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>OpenSAFELY Collaborative</CollectiveName></Author><Author ValidYN="Y"><LastName>Herrett</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eggo</LastName><ForeName>Rosalind M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Reg Health Eur</MedlineTA><NlmUniqueID>101777707</NlmUniqueID><ISSNLinking>2666-7762</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HRQoL</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">PROMs</Keyword><Keyword MajorTopicYN="N">QALY</Keyword></KeywordList><CoiStatement>BG has received funding via the University of Oxford from a wide range of public and charitable funders: the NHS National Institute for Health Research (NIHR), NHS England, the NIHR School of Primary Care Research, the NIHR Oxford Biomedical Research Centre, the Peter&#xa0;Bennett Foundation, the Laura and John Arnold Foundation, the Mohn-Westlake Foundation, NIHR Applied Research Collaboration Oxford and Thames Valley, UKRI/MRC, the Wellcome Trust, the Good Thinking Foundation, Health Data Research UK, the Health Foundation, and the World Health Organisation; he also receives personal income from speaking and writing for lay audiences on the misuse of science. He led the Goldacre Review (&#x201c;Better, broader, safer: using health data for research and analysis&#x201d; March 2022) for Secretary Of State for Health and Social Care; I chaired the HealthTech Advisory Board for Sec of State; I was a Non-Executive Director at NHS Digital; I am on the UKHSA Data Science Advisory Board; I have sat on various other local and national committees in the public sector. BMK is also employed by NHS England working on medicines policy and clinical lead for primary care medicines data. AM is a senior clinical researcher at the University of Oxford in the Bennett Institute, which is funded by contracts and grants obtained from the Bennett Foundation, Wellcome Trust, NIHR Oxford Biomedical Research Centre, NIHR Applied Research Collaboration Oxford and Thames Valley, Mohn-Westlake Foundation, and NHS England, and has consulted for health care vendors, the last time in 2022; the companies consulted in the last 3 years have no relationship to OpenSAFELY; he has represented the RCGP in the health informatics group and the Profession Advisory Group that advises on access to GP Data for Pandemic Planning and Research (GDPPR); the latter was a paid role; and he is a former employee and interim Chief Medical Officer of NHS Digital. REC holds shares in AstraZeneca. AB has received consulting fees from AstraZeneca, Roche, Takeda, Daiichi-Sankyo, Eisai, Novartis, Idorsia and Rhythmn. LAT has received grants or contracts from MRC, Wellcome, NIHR and GSK for an epidemiological study of kidney disease (no personal payment received) and has consulted for Bayer in relation to an observational study of chronic kidney disease (no personal payment received); she has received support for attending the MHRA Expert advisory group on Women's health and is an unpaid member of 4 non-industry funded NIHR/MRC trial advisory committees. JP has acted as an expert witness for the GMC with all fees paid to the company, and is an employee of TPP who provide the SystmOne software. MJ received support from NIHR for the funding of this manuscript and has received research grants from BMGF, Gavi, RCUK, WHO, Wellcome Trust, European Commission, InnoHK, TFGH and CDC. All other authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Walker</LastName><ForeName>Alex</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Green</LastName><ForeName>Amelia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehrkar</LastName><ForeName>Amir</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schaffer</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brown</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goldacre</LastName><ForeName>Ben</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Butler-Cole</LastName><ForeName>Ben</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>MacKenna</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morton</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walters</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stables</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cunningham</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wood</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andrews</LastName><ForeName>Colm</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hickman</LastName><ForeName>George</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Curtis</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drysdale</LastName><ForeName>Henry</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dillingham</LastName><ForeName>Iain</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morley</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Massey</LastName><ForeName>Jon</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nab</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hopcroft</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fisher</LastName><ForeName>Louis</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bridges</LastName><ForeName>Lucy</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wiedemann</LastName><ForeName>Milan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>DeVito</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Macdonald</LastName><ForeName>Orla</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Inglesby</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Croker</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Park</LastName><ForeName>Robin</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Higgins</LastName><ForeName>Rose</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bacon</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davy</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maude</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Dwyer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ward</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Speed</LastName><ForeName>Victoria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hulme</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hart</LastName><ForeName>Liam</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stokes</LastName><ForeName>Pete</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhaskaran</LastName><ForeName>Krishnan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Costello</LastName><ForeName>Ruth</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cowling</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Douglas</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eggo</LastName><ForeName>Rosalind</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forbes</LastName><ForeName>Harriet</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grieve</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grint</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herrett</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Langan</LastName><ForeName>Sinead</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mahalingasivam</LastName><ForeName>Viyaasan</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mansfield</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathur</LastName><ForeName>Rohini</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>McDonald</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parker</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rentsch</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schultze</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smeeth</LastName><ForeName>Liam</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tazare</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tomlinson</LastName><ForeName>Laurie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walker</LastName><ForeName>Jemma</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williamson</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wing</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wong</LastName><ForeName>Angel</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zheng</LastName><ForeName>Bang</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bates</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cockburn</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parry</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hester</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harper</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Hanlon</LastName><ForeName>Shaun</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eavis</LastName><ForeName>Alex</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jarvis</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Avramov</LastName><ForeName>Dima</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Griffiths</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fowles</LastName><ForeName>Aaron</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parkes</LastName><ForeName>Nasreen</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perera</LastName><ForeName>Rafael</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harrison</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khunti</LastName><ForeName>Kamlesh</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sterne</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quint</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>1</Day><Hour>3</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38689605</ArticleId><ArticleId IdType="pmc">PMC11059448</ArticleId><ArticleId IdType="doi">10.1016/j.lanepe.2024.100908</ArticleId><ArticleId IdType="pii">S2666-7762(24)00074-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE  . NICE; 2020. COVID-19 rapid guideline: managing the long-term effects of COVID-19.https://www.nice.org.uk/guidance/ng188 Overview | COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Guidance | NICE. [cited 2023 Sep 6] Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., et al. Symptoms, complications and management of long COVID: a review. J&#xa0;R Soc Med. 2021;114(9):428&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>ONS  . 2023. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK - Office for National Statistics.https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2february2023 [cited 2023 Sep 6]. Available from:</Citation></Reference><Reference><Citation>GOV.UK  . 2023. Cases in the UK | coronavirus in the UK.https://coronavirus.data.gov.uk/details/cases [cited 2023 Sep 6]. Available from:</Citation></Reference><Reference><Citation>Walker S., Goodfellow H., Pookarnjanamorakot P., et al. Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study. BMJ Open. 2023;13(6)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10335413</ArticleId><ArticleId IdType="pubmed">37286327</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., et al. Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021;8:100186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandmann F.G., Tessier E., Lacy J., et al. Long-term health-related quality of life in non-hospitalized coronavirus disease 2019 (COVID-19) cases with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in England: longitudinal analysis and cross-sectional comparison with controls. Clin Infect Dis. 2022;75(1):e962&#x2013;e973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903473</ArticleId><ArticleId IdType="pubmed">35245941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontopantelis E., Stevens R.J., Helms P.J., Edwards D., Doran T., Ashcroft D.M. Spatial distribution of clinical computer systems in primary care in England in 2016 and implications for primary care electronic medical record databases: a cross-sectional population study. BMJ Open. 2018;8(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5855245</ArticleId><ArticleId IdType="pubmed">29490968</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrett E., Tomlin K., Lin L.Y., et al. Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT) BMJ Open. 2023;13(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9943695</ArticleId><ArticleId IdType="pubmed">36806073</ArticleId></ArticleIdList></Reference><Reference><Citation>UKRI  . 2016. MRC breathlessness scales: 1952 and 1959.https://www.ukri.org/publications/mrc-breathlessness-scales-1952-and-1959/ [cited 2023 Nov 26]. Available from:</Citation></Reference><Reference><Citation>Tennant K.F. 2011. Assessment of fatigue in older adults: the FACIT fatigue scale (version 4). Hartford Institute for geriatric nursing. [Try This: Best Practices in Nursing Care to Older Adults)]</Citation></Reference><Reference><Citation>Walker A.J., MacKenna B., Inglesby P., et al. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br J Gen Pract. 2021;71(712):e806&#x2013;e814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340730</ArticleId><ArticleId IdType="pubmed">34340970</ArticleId></ArticleIdList></Reference><Reference><Citation>LSHTM . 2022. OpenPROMPT | LSHTM.https://www.lshtm.ac.uk/research/centres-projects-groups/openprompt [cited 2023 Jul 10]. Available from:</Citation></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>GOV.UK  . 2019. The English indices of deprivation 2019.https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/835115/IoD2019_Statistical_Release.pdf Available from:</Citation></Reference><Reference><Citation>Devlin N.J., Brooks R. EQ-5D and the EuroQol group: past, present and future. Appl Health Econ Health Policy. 2017;15(2):127&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5343080</ArticleId><ArticleId IdType="pubmed">28194657</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez Alava M., Pudney S., Wailoo A. Estimating the relationship between EQ-5D-5L and EQ-5D-3L: results from a UK population study. Pharmacoeconomics. 2023;41(2):199&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9883358</ArticleId><ArticleId IdType="pubmed">36449173</ArticleId></ArticleIdList></Reference><Reference><Citation>van Hout B., Janssen M.F., Feng Y.S., et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708&#x2013;715.</Citation><ArticleIdList><ArticleId IdType="pubmed">22867780</ArticleId></ArticleIdList></Reference><Reference><Citation>McNamara S., Schneider P.P., Love-Koh J., Doran T., Gutacker N. Quality-adjusted life expectancy norms for the English population. Value Health. 2023;26(2):163&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">35965226</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsen J.C., Gluud C., Wetterslev J., Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials&#x2014;a practical guide with flowcharts. BMC Med Res Methodol. 2017;17(1):162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5717805</ArticleId><ArticleId IdType="pubmed">29207961</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter R.M., Baio G., Butt T., Morris S., Round J., Freemantle N. An&#xa0;educational review of the statistical issues in analysing utility data for cost-utility analysis. Pharmacoeconomics. 2015;33(4):355&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">25595871</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>McClure N.S., Sayah F.A., Xie F., Luo N., Johnson J.A. Instrument-defined estimates of the minimally important difference for EQ-5D-5L index scores. Value Health. 2017;20(4):644&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pubmed">28408007</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt H., Relton C., Talaei M., et al. Cohort Profile: longitudinal population-based study of COVID-19 in UK adults (COVIDENCE UK) Int J Epidemiol. 2022:dyac189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9620716</ArticleId><ArticleId IdType="pubmed">36174228</ArticleId></ArticleIdList></Reference><Reference><Citation>Maheswaran H., Kupek E., Petrou S. Self-reported health and socio-economic inequalities in England, 1996&#x2013;2009: repeated national cross-sectional study. Soc Sci Med. 2015;136&#x2013;137:135&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4510149</ArticleId><ArticleId IdType="pubmed">26004207</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Fusco M., Cappelleri J.C., Anatale-Tardiff L., et al. Impact of COVID-19 infection on health-related quality of life, work productivity and activity impairment by symptom-based long COVID status and age in the US. Healthcare. 2023;11(20):2790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10606451</ArticleId><ArticleId IdType="pubmed">37893865</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler C.X., Wyller V.B.B., Moss-Morris R., et al. Long COVID and post-infective fatigue syndrome: a review. Open Forum Infect Dis. 2021;8(10)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Montan I., L&#xf6;we B., Cella D., Mehnert A., Hinz A. General population norms for the functional assessment of chronic illness Therapy (FACIT)-Fatigue scale. Value Health. 2018;21(11):1313&#x2013;1321.</Citation><ArticleIdList><ArticleId IdType="pubmed">30442279</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens M., Duarte R.V., De Smedt A., et al. Health-related quality of life in persons post-COVID-19 infection in comparison to normative controls and chronic pain patients. Front Public Health. 2022;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9632164</ArticleId><ArticleId IdType="pubmed">36339175</ArticleId></ArticleIdList></Reference><Reference><Citation>Arab-Zozani M., Hashemi F., Safari H., Yousefi M., Ameri H. Health-related quality of life and its associated factors in COVID-19 patients. Osong Public Health Res Perspect. 2020;11(5):296&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577388</ArticleId><ArticleId IdType="pubmed">33117634</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., McAuley H., Harrison E.M., et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9(11):1275&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Squire I., Glover J., Corp J., Haroun R., Kuzan D., Gielen V. Impact of HF on HRQoL in patients and their caregivers in England: results from the ASSESS study - the British Journal of Cardiology. BJC. 2017;(34):24&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Carney P., O'Boyle D., Larkin A., McGuigan C., O'Rourke K. Societal costs of multiple sclerosis in Ireland. J&#xa0;Med Econ. 2018;21(5):425&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pubmed">29320900</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Lau T., Lee E., Vathsala A., Chia K.S., Luo N. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD) Eur J Health Econ. 2015;16(9):1019&#x2013;1026.</Citation><ArticleIdList><ArticleId IdType="pubmed">25519850</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan C.M., Longworth L., Lord J., et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax. 2016;71(6):493&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4893131</ArticleId><ArticleId IdType="pubmed">27030578</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson A.D., Butler-Cole B.F., Tazare J., et al. Clinical coding of long COVID in primary care 2020-2023 in a cohort of 19 million adults: an OpenSAFELY analysis. medRxiv. 2023 doi: 10.1101/2023.12.04.23299364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.12.04.23299364</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson A.D., Carlile O., Dillingham I., et al. Cohort profile: OpenPROMPT. medRxiv. 2023 doi: 10.1101/2023.12.21.23300369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.12.21.23300369</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman M., Prashar J., Hillman T.E., et al. Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Respir Res. 2021;8(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="pubmed">34764200</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews C., Schultze A., Curtis H., et al. OpenSAFELY: representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England. Wellcome Open Res. 2022;7:191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9346309</ArticleId><ArticleId IdType="pubmed">35966958</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabnam S., Razieh C., Dambha-Miller H., et al. Socioeconomic inequalities of Long COVID: a retrospective population-based cohort study in the United Kingdom. J&#xa0;R Soc Med. 2023;116(8):263&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10469969</ArticleId><ArticleId IdType="pubmed">37164035</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosworth M.L., Ahmed T., Larsen T., et al. Ethnic differences in COVID-19 mortality in the second and third waves of the pandemic in England during the vaccine rollout: a retrospective, population-based cohort study. BMC Med. 2023;21(1):13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9826727</ArticleId><ArticleId IdType="pubmed">36617562</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T., Menges D., Anagnostopoulos A., et al. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ. 2023;381</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin C., Luteijn M., Letton W., Robertson J., McDonald S. A&#xa0;model framework for projecting the prevalence and impact of Long-COVID in the UK. PLoS One. 2021;16(12)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8639065</ArticleId><ArticleId IdType="pubmed">34855874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L.Y., Henderson A.D., Carlile O., et al. Healthcare utilisation in people with long COVID: an OpenSAFELY cohort study. medRxiv. 2023 doi: 10.1101/2023.12.21.23300305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.12.21.23300305</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuschke D., Houston D. The impact of Long COVID on the UK workforce. Appl Econ Lett. 2023;30(18):2510&#x2013;2514.</Citation></Reference><Reference><Citation>Greenhalgh T., Sivan M., Delaney B., Evans R., Milne R. Long covid&#x2014;an update for primary care. BMJ. 2022;378</Citation><ArticleIdList><ArticleId IdType="pubmed">36137612</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>